A Structural Comparison Approach for Identifying Small Variations in Binding Sites of Homologous Proteins


A method for analyzing the protein site similarity was devised aiming at understanding selectivity of homologous proteins and guiding the design of new drugs. The method is based on calculating Cα distances between selected pocket residues and subsequent analysis by multivariate methods. Five closely related serine proteases, the coagulation factors II, VII, IX, X, and XI, were studied and their pocket similarity was illustrated by PCA clustering. OPLS-DA was then applied to identify the residues responsible for the variation. By combining these two multivariate methods, we could successfully cluster the different proteases according to class and identify the important residues responsible for the observed variation.

Share and Cite:

Uzelac, I. , Olsson, T. , Eriksson, L. and Gottfries, J. (2015) A Structural Comparison Approach for Identifying Small Variations in Binding Sites of Homologous Proteins. Computational Molecular Bioscience, 5, 45-55. doi: 10.4236/cmb.2015.53006.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Weber, A., Casini, A., Heine, A., Kuhn, D., Supuran, C.T., Scozzafava, A. and Klebe, G. (2004) Unexpected Nanomolar Inhibition of Carbonic Anhydrase by COX-2-Selective Celecoxib: New Pharmacological Opportunities Due to Related Binding Site Recognition. Journal of Medicinal Chemistry, 47, 550-557.
[2] Arrowsmith, J. and Miller, P. (2013) Phase II and Phase III attrition rates 2011-2012. Nature Reviews Drug Discovery, 12, 568-568.
[3] Giacomini, K.M., Krauss, R.M., Roden, D.M., Eichelbaum, M. and Hayden, M.R. (2007) When Good Drugs Go Bad. Nature, 446, 975-977.
[4] Pearson, H. (2006) The Bitterest Pill. Nature, 444, 532-533.
[5] Haupt, V.J., Daminelli, S. and Schroeder, M. (2013) Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key. PLoS ONE, 8, e65894.
[6] Sturm, N., Desaphy, J., Quinn, R.J., Rognan, D. and Kellenberger, E. (2012) Structural Insights into the Molecular Basis of the Ligand Promiscuity. Journal of Chemical Information and Modeling, 52, 2410-2421.
[7] Hendlich, M., Rippmann, F. and Barnickel, G. (1997) LIGSITE: Automatic and Efficient Detection of Potential Small Molecule-Binding Sites in Proteins. Journal of Molecular Graphics and Modelling, 15, 359-363.
[8] Laurie, A.T.R. and Jackson, R.M. (2005) Q-Site Finder: An Energy-Based Method for the Prediction of Protein-Ligand Binding Sites. Bioinformatics, 21, 1908-1916.
[9] Schmitt, S., Kuhn, D. and Klebe, G. (2002) A New Method to Detect Related Function among Proteins Independent of Sequence and Fold Homology. Journal of Molecular Biology, 323, 387-406.
[10] Halgren, T. (2007) New Method for Fast and Accurate Binding-Site Identification and Analysis. Chemical Biology & Drug Design, 69, 146-148.
[11] Jalencas, X. and Mestres, J. (2013) Identification of Similar Binding Sites to Detect Distant Polypharmacology. Molecular Informatics, 32, 976-990.
[12] Perot, S., Sperandio, O., Miteva, M.A., Camproux, A.C. and Villoutreix, B.O. (2010) Druggable Pockets and Binding Site Centric Chemical Space: A Paradigm Shift in Drug Discovery. Drug Discovery Today, 15, 656-667.
[13] Rosen, M., Lin, S.L., Wolfson, H. and Nussinov, R. (1998) Molecular Shape Comparisons in Searches for Active Sites and Functional Similarity. Protein Engineering, Design and Selection, 11, 263-277.
[14] Kupas, K., Ultsch, A. and Klebe, G. (2008) Large Scale Analysis of Protein-Binding Cavities Using Self-Organizing Maps and Wavelet-Based Surface Patches to Describe Functional Properties, Selectivity Discrimination, and Putative Cross-Reactivity. Proteins: Structure, Function, and Bioinformatics, 71, 1288-1306.
[15] Kalliokoski, T., Olsson, T.S.G. and Vulpetti, A. (2013) Subpocket Analysis Method for Fragment-Based Drug Discovery. Journal of Chemical Information and Modeling, 53, 131-141.
[16] Xiong, B., Wu, J., Burk, D.L., Xue, M.Z., Jiang, H.L. and Shen, J.K. (2010) BSSF: A Fingerprint Based Ultrafast Binding Site Similarity Search and Function Analysis Server. BMC Bioinformatics, 11, 47.
[17] Feldman, H.J. and Labute, P. (2010) Pocket Similarity: Are Alpha Carbons Enough? Journal of Chemical Information and Modeling, 50, 1466-1475.
[18] Powers, R., Copeland, J.C., Germer, K., Mercier, K.A., Ramanathan, V. and Revesz, P. (2006) Comparison of Protein Active Site Structures for Functional Annotation of Proteins and Drug Design. Proteins: Structure, Function, and Bioinformatics, 65, 124-135.
[19] Minai, R., Matsuo, Y., Onuki, H. and Hirota, H. (2008) Method for Comparing the Structures of Protein Ligand-Binding Sites and Application for Predicting Protein-Drug Interactions. Proteins: Structure, Function, and Bioinformatics, 72, 367-381.
[20] Wallace, A.C., Borkakoti, N. and Thornton, J.M. (1997) TESS: A Geometric Hashing Algorithm for Deriving 3D Coordinate Templates for Searching Structural Databases. Application to Enzyme Active Sites. Protein Science, 6, 2308-2323.
[21] Artymiuk, P.J., Poirrette, A.R., Grindley, H.M., Rice, D.W. and Willett, P. (1994) A Graph-Theoretic Approach to the Identification of 3-Dimensional Patterns of Amino-Acid Side-Chains in Protein Structures. Journal of Molecular Biology, 243, 327-344.
[22] Jackson, J.E. (1991) A User’s Guide to Principal Component Analysis. John Wiley & Sons, Hoboken.
[23] Kastenholz, M.A., Pastor, M., Cruciani, G., Haaksma, E.E.J. and Fox, T. (2000) GRID/CPCA: A New Computational Tool to Design Selective Ligands. Journal of Medicinal Chemistry, 43, 3033-3044.
[24] Andersson, C.D., Chen, B.Y. and Linusson, A. (2010) Mapping of Ligand-Binding Cavities in Proteins. Proteins: Structure, Function, and Bioinformatics, 78, 1408-1422.
[25] Desdouits, N., Nilges, M. and Blondel, A. (2015) Principal Component Analysis Reveals Correlation of Cavities Evolution and Functional Motions in Proteins. Journal of Molecular Graphics and Modelling, 55, 13-24.
[26] Bylesjo, M., Rantalainen, M., Cloarec, O., Nicholson, J.K., Holmes, E. and Trygg, J. (2006) OPLS Discriminant Analysis: Combining the Strengths of PLS-DA and SIMCA Classification. Journal of Chemometrics, 20, 341-351.
[27] Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N. and Bourne, P.E. (2000) The Protein Data Bank. Nucleic Acids Research, 28, 235-242.
[28] Prasad, S., Cantwell, A.M., Bush, L.A., Shih, P., Xu, H. and Di Cera, E. (2004) Residue Asp-189 Controls both Substrate Binding and the Monovalent Cation Specificity of Thrombin. The Journal of Biological Chemistry, 279, 10103-10108.
[29] Wold, S., Esbensen, K. and Geladi, P. (1987) Principal Component Analysis. Chemometrics and Intelligent Laboratory Systems, 2, 37-52.
[30] Trygg, J. and Wold, S. (2002) Orthogonal Projections to Latent Structures (O-PLS). Journal of Chemometrics, 16, 119-128.
[31] Pozzi, N., Chen, Z.W., Zapata, F., Pelc, L.A., Barranco-Medina, S. and Di Cera, E. (2011) Crystal Structures of Prethrombin-2 Reveal Alternative Conformations under Identical Solution Conditions and the Mechanism of Zymogen Activation. Biochemistry, 50, 10195-10202.
[32] Johnson, D.J.D., Adams, T.E., Li, W. and Huntington, J.A. (2005) Crystal Structure of Wild-Type Human Thrombin in the Na+-Free State. Biochemical Journal, 392, 21-28.
[33] Eigenbrot, C., Kirchhofer, D., Dennis, M.S., Santell, L., Lazarus, R.A., Stamos, J. and Ultsch, M.H. (2001) The Factor VII Zymogen Structure Reveals Reregistration of Beta Strands during Activation. Structure, 9, 627-636.
[34] Gandhi, P.S., Page, M.J., Chen, Z.W., Bush-Pelc, L. and Di Cera, E. (2009) Mechanism of the Anticoagulant Activity of Thrombin Mutant W215A/E217A. The Journal of Biological Chemistry, 284, 24098-24105.
[35] Katayama, K., Ericsson, L.H., Enfield, D.L., Walsh, K.A., Neurath, H., Davie, E.W. and Titani, K. (1979) Comparison of Amino-Acid Sequence of Bovine Coagulation Factor-IX (Christmas Factor) with That of Other Vitamin K-Dependent Plasma-Proteins. Proceedings of the National Academy of Sciences of the United States of America, 76, 4990-4994.
[36] Brandstetter, H., Bauer, M., Huber, R., Lollar, P. and Bode, W. (1995) X-Ray Structure of Clotting Factor IXa: Active-Site and Module Structure Related to Xase Activity and Hemophilia B. Proceedings of the National Academy of Sciences of the United States of America, 92, 9796-9800.
[37] Shirk, R.A. and Vlasuk, G.P. (2007) Inhibitors of Factor VIIa/Tissue Factor. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1895-1900.
[38] Kortagere, S., Ekins, S. and Welsh, W.J. (2008) Halogenated Ligands and Their Interactions with Amino Acids: Implications for Structure-Activity and Structure-Toxicity Relationships. Journal of Molecular Graphics and Modelling, 27, 170-177.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.